89bio, Inc. ETNB
Set alert
14.84 0.00 0.00%
At close · Oct 30
14.84 Day range 14.84
52-week range unavailable
- YTD
- +89.77%
- 1 year
- +85.73%
- Open
- 14.84
- Prev close
- 14.84
- Mkt cap
- 2.20B
- Vol
- 38.51M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.84
- High
- 14.84
- Forward P/E
- -5.17
- Beta
- 1.26
- Short ratio
- 0.74
- Inst. own
- 103.69%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 12.52
- 200-d avg
- 9.87
- 1y target
- 30.38
2Y chart
Events in this range
- Mar 14, 2025Rating: Goldman Sachs · — → Neutral
- Aug 8, 2025Rating: RBC Capital · Sector Perform → Sector Perform
- Aug 25, 2025Rating: B of A Securities · Buy → Buy
- Sep 19, 2025Downgrade: HC Wainwright & Co. · Buy → Neutral
- Sep 19, 2025Downgrade: Wolfe Research · Outperform → Peer Perform
- Sep 19, 2025Downgrade: Raymond James · Outperform → Market Perform
Signals (95)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 9, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 18, 2025 | 1 year ago |
| RSI: Overbought | Sep 18, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 5, 2025 | 1 year ago |
| SMA: Bearish | Sep 4, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 4, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 20, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 19, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Jul 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 12, 2025 | 1 year ago |
| RSI: Overbought | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | May 20, 2025 | 1 year ago |
| MACD: Buy Signal | May 20, 2025 | 1 year ago |
| MACD: Sell Signal | May 19, 2025 | 1 year ago |
| SMA: Bearish | May 6, 2025 | 1 year ago |
| SMA: Bullish | May 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 30, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 17, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 28, 2025 | 1 year ago |
| SMA: Bullish | Mar 27, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| SMA: Bullish | Mar 24, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 19, 2025 | 1 year ago |
| SMA: Bullish | Mar 14, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| SMA: Bearish | Mar 6, 2025 | 1 year ago |
| SMA: Bearish | Mar 4, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 21, 2025 | 1 year ago |
| RSI: Overbought | Feb 11, 2025 | 1 year ago |
| RSI: Overbought | Feb 4, 2025 | 1 year ago |
| RSI: Overbought | Jan 30, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 24, 2025 | 1 year ago |
| RSI: Oversold | Jan 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 8, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 26, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 4, 2024 | 1 year ago |
| SMA: Bearish | Dec 3, 2024 | 1 year ago |
| SMA: Bullish | Dec 2, 2024 | 1 year ago |
| SMA: Bearish | Nov 29, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 29, 2024 | 1 year ago |
| SMA: Bullish | Nov 27, 2024 | 1 year ago |
| SMA: Bullish | Nov 21, 2024 | 1 year ago |
| SMA: Bearish | Nov 15, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 14, 2024 | 1 year ago |
| SMA: Bearish | Nov 12, 2024 | 1 year ago |
| RSI: Overbought | Nov 6, 2024 | 1 year ago |
| SMA: Bullish | Nov 1, 2024 | 1 year ago |
| SMA: Bearish | Oct 30, 2024 | 2 years ago |
| SMA: Bullish | Oct 29, 2024 | 2 years ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| SMA: Bullish | Oct 16, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 10, 2024 | 2 years ago |
| SMA: Bearish | Sep 6, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 6, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 20, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 5, 2024 | 2 years ago |
| SMA: Bullish | Jul 23, 2024 | 2 years ago |
| SMA: Bearish | Jul 18, 2024 | 2 years ago |
| SMA: Bullish | Jul 10, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 9, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 25, 2024 | 2 years ago |
| SMA: Bearish | Jun 14, 2024 | 2 years ago |
| SMA: Bullish | Jun 12, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 6, 2024 | 2 years ago |
| MACD: Sell Signal | May 24, 2024 | 2 years ago |
| MACD: Buy Signal | May 2, 2024 | 2 years ago |
| RSI: Oversold | Apr 25, 2024 | 2 years ago |
| RSI: Oversold | Apr 18, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 19, 2024 | 2 years ago |
| RSI: Overbought | Mar 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 21, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 15, 2024 | 2 years ago |
| RSI: Oversold | Feb 6, 2024 | 2 years ago |
| SMA: Bearish | Jan 31, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 10, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 8, 2024 | 2 years ago |
| RSI: Overbought | Jan 8, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 3, 2024 | 2 years ago |
| RSI: Overbought | Dec 28, 2023 | 2 years ago |
| RSI: Overbought | Dec 12, 2023 | 2 years ago |
| RSI: Overbought | Dec 5, 2023 | 2 years ago |
Key statistics
- Market cap
- 2.20B
- Enterprise value
- 1.68B
- Trailing P/E
- 0.00
- Forward P/E
- -5.17
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 4.22
- EPS (TTM)
- -3.69
- Beta
- 1.26
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -257.73M
- Total cash
- 561.16M
- Total debt
- 37.62M
- Return on equity
- -86.86%
- Shares outstanding
- 148.49M
- Short % of float
- 6.30%
- 50-day average
- 12.52
- 200-day average
- 9.87
Analyst view
Consensus: buy
Buy
Price target (mean) 30.38 +104.7% upside
Now 14.84
- Target (low)
- 14.50
- Target (mean)
- 30.38
- Target (high)
- 55.00
Ratings (0m) 6 2 buy · 4 hold · 0 sell
- Strong buy0
- Buy2
- Hold4
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.49667.
Financials — quick view
ETNB Revenue — quarterly 0
ETNB Net income — quarterly -111.50M
ETNB EPS — quarterly -0.71
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 19, 2025 | Raymond James | down | Outperform | Market Perform |
| Sep 19, 2025 | Wolfe Research | down | Outperform | Peer Perform |
| Sep 19, 2025 | HC Wainwright & Co. | down | Buy | Neutral |
| Aug 25, 2025 | B of A Securities | main | Buy | Buy |
| Aug 8, 2025 | RBC Capital | main | Sector Perform | Sector Perform |
| Mar 14, 2025 | Goldman Sachs | init | — | Neutral |
About 89bio, Inc.
89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of metabolic dysfunction-associated steatohepatitis and hypertriglyceridemia. 89bio, Inc. was formerly known as The company was founded in 2018 and is based in San Francisco, California. As of October 29, 2025, 89bio, Inc. operates as a subsidiary of Roche Holding AG.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- 89bio.com
News
- Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday
- Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge
- Top 2 Health Care Stocks That May Keep You Up At Night This Month
- Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
- Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Dada Nexus, Titan Machinery, AT&T And Other Big Stocks Moving Higher On Monday
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
Your note
Sign in to keep a note on ETNB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| LE-NGUYEN QUOC | Chief Operating Officer | Stock Award(Grant) | Oct 29, 2025 | 0 |
| MANSBACH HARRY H | Officer | Stock Award(Grant) | Jan 30, 2025 | 323,701 |
| MARTINS RYAN | Chief Financial Officer | Conversion of Exercise of derivative security | Oct 21, 2025 | 339,295 |
| MCWHERTER CHARLES A | Director | Purchase | Jan 21, 2025 | 25,000 |
| PALEKAR ROHAN | Chief Executive Officer | Stock Award(Grant) | Jan 30, 2025 | 873,638 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 29, 2025 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Janus Henderson Group PLC | 14.02% | 20,788,363 | 308.50M | Jun 29, 2025 |
| RA Capital Management, L.P. | 13.41% | 19,889,683 | 295.16M | Jun 29, 2025 |
| Suvretta Capital Management, LLC | 9.58% | 14,210,000 | 210.88M | Jun 29, 2025 |
| Blackrock Inc. | 7.13% | 10,569,424 | 156.85M | Jun 29, 2025 |
| Deep Track Capital, Lp | 6.41% | 9,500,000 | 140.98M | Jun 29, 2025 |
| Vanguard Group Inc | 5.56% | 8,242,154 | 122.31M | Jun 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.24% | 4,805,776 | 71.32M | Jun 29, 2025 |
| iShares Trust-iShares Russell 2000 ETF | 2.07% | 3,065,984 | 45.50M | Sep 29, 2025 |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 1.97% | 2,923,449 | 43.38M | Jun 29, 2025 |
| SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF | 1.72% | 2,552,389 | 37.88M | Sep 29, 2025 |
| JANUS INVESTMENT FUND-Janus Henderson Triton Fund | 1.58% | 2,345,178 | 34.80M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.35% | 2,007,886 | 29.80M | Jun 29, 2025 |